Anti-Atherogenic Mechanisms and Therapies

Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1): 56. https://doi.org/10.1038/s41572-019-0106-z.

Article  PubMed  Google Scholar 

Bjorkegren JLM, Lusis AJ. Atherosclerosis: Recent developments. Cell. 2022;185(10):1630–45. https://doi.org/10.1016/j.cell.2022.04.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez AL, Dungan MM, Smart CD, Madhur MS, Doran AC. Inflammation resolution in the cardiovascular system: arterial hypertension, atherosclerosis, and ischemic heart disease. Antioxid Redox Signal. 2024;40(4–6):292–316. https://doi.org/10.1089/ars.2023.0284.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Back M, Yurdagul A Jr, Tabas I, Oorni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389–406. https://doi.org/10.1038/s41569-019-0169-2.

Article  PubMed  PubMed Central  Google Scholar 

Stroope C, Nettersheim FS, Coon B, Finney AC, Schwartz MA, Ley K, et al. Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities. Nat Metab. 2024;6(4):617–38. https://doi.org/10.1038/s42255-024-01015-w.

Article  PubMed  PubMed Central  Google Scholar 

Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254–67. https://doi.org/10.1038/s41577-019-0240-6.

Article  CAS  PubMed  Google Scholar 

Adkar SS, Leeper NJ. Efferocytosis in atherosclerosis. Nat Rev Cardiol. 2024;21(11):762–79. https://doi.org/10.1038/s41569-024-01037-7.

Article  PubMed  Google Scholar 

Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I. The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation. Immunol Rev. 2023;319(1):65–80. https://doi.org/10.1111/imr.13214.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–55. https://doi.org/10.1016/j.cell.2011.04.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doran AC. Inflammation resolution: implications for atherosclerosis. Circ Res. 2022;130(1):130–48. https://doi.org/10.1161/CIRCRESAHA.121.319822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar D, Pandit R, Yurdagul A Jr. Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism. 2023;5(1): e00017. https://doi.org/10.1097/IN9.0000000000000017.

Article  PubMed  Google Scholar 

Yurdagul A Jr. Crosstalk between macrophages and vascular smooth muscle cells in atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. 2022;42(4):372–80. https://doi.org/10.1161/ATVBAHA.121.316233.

Schilperoort M, Ngai D, Katerelos M, Power DA, Tabas I. PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages. Nat Metab. 2023;5(3):431–44. https://doi.org/10.1038/s42255-023-00736-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabas I, Bornfeldt KE. Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ Res. 2020;126(9):1209–27. https://doi.org/10.1161/CIRCRESAHA.119.315939.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seeley EH, Liu Z, Yuan S, Stroope C, Cockerham E, Rashdan NA, et al. Spatially resolved metabolites in stable and unstable human atherosclerotic plaques identified by mass spectrometry imaging. Arterioscler Thromb Vasc Biol. 2023;43(9):1626–35. https://doi.org/10.1161/ATVBAHA.122.318684.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gastanadui MG, Margaroli C, Litovsky S, Richter RP, Wang D, Xing D, et al. Spatial transcriptomic approach to understanding coronary atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol. 2024;44(11):e264-76. https://doi.org/10.1161/ATVBAHA.123.320330.

Article  CAS  PubMed  Google Scholar 

Sun J, Singh P, Shami A, Kluza E, Pan M, Djordjevic D, et al. Spatial transcriptional mapping reveals site-specific pathways underlying human atherosclerotic plaque rupture. J Am Coll Cardiol. 2023;81(23):2213–27. https://doi.org/10.1016/j.jacc.2023.04.008.

Article  CAS  PubMed  Google Scholar 

Willemsen L, de Winther MP. Macrophage subsets in atherosclerosis as defined by single-cell technologies. J Pathol. 2020;250(5):705–14. https://doi.org/10.1002/path.5392.

Article  PubMed  PubMed Central  Google Scholar 

Steinberg D, Witztum JL. Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(12):2311–6. https://doi.org/10.1161/ATVBAHA.108.179697.

Article  CAS  PubMed  Google Scholar 

Poznyak AV, Nikiforov NG, Markin AM, Kashirskikh DA, Myasoedova VA, Gerasimova EV, et al. Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis. Front Pharmacol. 2020;11: 613780. https://doi.org/10.3389/fphar.2020.613780.

Article  CAS  PubMed  Google Scholar 

Yurdagul A Jr, Green J, Albert P, McInnis MC, Mazar AP, Orr AW. alpha5beta1 integrin signaling mediates oxidized low-density lipoprotein-induced inflammation and early atherosclerosis. Arterioscler Thromb Vasc Biol. 2014;34(7):1362–73. https://doi.org/10.1161/ATVBAHA.114.303863.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yurdagul A Jr, Sulzmaier FJ, Chen XL, Pattillo CB, Schlaepfer DD, Orr AW. Oxidized LDL induces FAK-dependent RSK signaling to drive NF-kappaB activation and VCAM-1 expression. J Cell Sci. 2016;129(8):1580–91. https://doi.org/10.1242/jcs.182097.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–61. https://doi.org/10.1038/nature08938.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol. 2000;81(3):173–82. https://doi.org/10.1046/j.1365-2613.2000.00155.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernandez GE, Ma F, Martinez G, Firozabadi NB, Salvador J, Juang LJ, et al. Aortic intimal resident macrophages are essential for maintenance of the non-thrombogenic intravascular state. Nat Cardiovasc Res. 2022;1(1):67–84. https://doi.org/10.1038/s44161-021-00006-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9(1): 130. https://doi.org/10.1038/s41392-024-01840-1.

Article  PubMed  PubMed Central  Google Scholar 

Satish M, Agrawal DK. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition. Transl Res. 2020;215:75–85. https://doi.org/10.1016/j.trsl.2019.08.003.

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif